Cilostazol losantel Sodium a signature event during apoptosis

a signature event during apoptosis

and p53 signalling pathways

InChiKey: XWIHRGFIPXWGEF-YYEJEILISA-N

Smiles: CC1C=C(C=CC=1)C#C[C@]1(O)CCC[C@@H]2[C@H]1CCN2C(=O)OC

L002 was used at 5-30 µM final concentration in various in vitro assays

Cilostazol losantel Sodium a signature event during apoptosisCilostazol is a quinolinone derivative medication used in the alleviation of the symptom of claudication in individuals with peripheral vascular disease. Cilostazol is a phosphodiesterase inhibitor with therapeutic focus on cyclic adenosine monophosphate (cAMP). It inhibits platelet aggregation and is a direct arterial vasodilator. Its main effects are dilation of the arteries supplying blood to the legs and decreasing platelet coagulation. It is